News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
AstraZeneca PLC Aims to Sell Nasal Flu Vaccine in EU
January 6, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
LONDON, Jan 6 (Reuters) - AstraZeneca hopes to sell a nasal spray flu vaccine that is already available in the United States in Europe as well.
Twitter
LinkedIn
Facebook
Email
Print
Europe
AstraZeneca Pharmaceuticals LP
MORE ON THIS TOPIC
Funding
Novo Foundation Pumps $850M Into Denmark, Europe to Bolster Innovation
January 16, 2026
·
2 min read
·
Tristan Manalac
Job Trends
3 Top Challenges Facing Manufacturing Professionals Right Now
January 15, 2026
·
6 min read
·
Angela Gabriel
Policy
Acadia CEO Bands With Peers To Lobby Against MFN Drug Pricing for Small Biotech
January 13, 2026
·
3 min read
·
Annalee Armstrong
Business
Basel Life Sciences Scene Embraces International Companies, Startups
November 6, 2025
·
6 min read
·
Angela Gabriel
